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1. Introduction  
Hepatocyte growth factor (HGF), also known as a scatter factor plays a major role in liver 
repair and regeneration during injury. HGF displays a complex network of signaling 
pathways that activate key functions for liver repair, survival and cellular redox control 
(Gomez-Quiroz, et al. 2008; Nakamura and Mizuno 2010) all these functions are initiated by 
the binding of HGF to its receptor c-Met which, after autophosphorylation, recruits a wide 
variety of signal transduction proteins. 
After injury, liver initiates repair process which could be leaded by proliferation of the 
mature, and normally quiescent, hepatocytes or, when damage is extensive and mature 
hepatocytes are enable to proliferate, by the activation of progenitor cells population or oval 
cells (Riehle, et al. 2011) 
It is well recognized that the repair process begins with the activation of Kupffer cells, the 
liver-resident macrophagues, which respond to damage secreting tumor necrosis factor 
alpha (TNF-) and interleukin (IL-) 6, these cytokines induce the activation of signaling 
pathways in hepatocytes such as nuclear factor κB (NF-κB) and signal transducer and 
activator of transcription 3 (Stat3), respectively. In addition, hepatic stellate cells (HSC) and 
inflammatory cells initiate the production of HGF which together with TNF- and IL-6 lead 
to a cooperative signal to overcome cell-cycle checkpoint controls and shift cells from G0 
through G1, to S phase, leading to hepatocytes proliferation and repair.(Riehle et al. 2011) 
2. HGF/c-Met and its function in liver repair  
HGF gene is encoded on chromosome 7 band 7q21.1 and its product is a precursor 
glycopolypeptide of 697 amino acids which is proteolytic processed in the extracellular 
environment by the serine endoprotease urokinase-type plasminogen activator (uPA) 
(Naldini, et al. 1992) generating the mature HGF consisting in a heterodimeric disulphide-
linked two polypeptide chains ( and ǃ). The -chain consists of 463 amino acids residues 
and four kringle domains. The ǃ-chain consists of 234 amino acid residues. It is thought that 
in vivo HGF acts in a paracrine fashion, being produced by mesenchymal or stromal cells 
(Stoker, et al. 1987), and targeting epithelial cells nearby (Sonnenberg, et al. 1993). 
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Among the multiple biological function triggered by HGF is important underline: cell 
proliferation, apoptosis protection, morphogenesis, scattering, cell motility, invasion and 
metastasis (Hanna, et al. 2009). The signal transduction that drives all these effects starts by 
the ligand-induced dimerization and activation of the HGF receptor, the proto-oncogen c-
Met (cellular-mesenchymal epithelial transition factor) (Ma, et al. 2003). 
Human c-Met gene is located on chromosome 7 band 7q21-q31; the product is a 150-kDa 
polypeptide that, after glycosylation and proteolytic processing, generates the mature ǂ-ǃ 
heterodimer receptor composed of one extracellular 50-kDa -chain linked by disulfide 
bonds to a transmembrane 140-kDa ǃ-chain. The ǃ-subunit encloses multiple sites of 
regulatory phosphorylation. Ligand binding to the receptor leads to autophosphorylation of 
the tyrosines 1230, 1234 and 1235 located within the activation loop of the tyrosine kinase 
domain and activates the intrinsic kinase activity of the receptor. (Ma et al. 2003). 
HGF also induces tyrosine 1313 phosphorylation which is preferred by phosphoinositide 3-
kinase (PI3K) binding, while in the multi-substrate signal transducer docking site, located in 
the  C-terminus domain, phosphorylation of tyrosines 1349, and 1356 lead to the activation 
of adapter and effectors proteins such as Shc, Src, Gab1, Grb2, PI3K, SHP2, phospholipase C-
Ǆ (PLC-Ǆ) among others (Bertotti and Comoglio 2003), these pathways have been widely 
characterized both in vivo and in vitro, and it has been well defined the difference between 
HGF and other growth factors with tissue repair activities such as epidermal growth factor 
(EGF), TNF-, or IL-6. Under this context it has been reported that HGF promotes 
tubulogenesis by the activation of GAB1, SHP-2, and Stat3; survival and antiapoptosis by 
NF-κB, Stat3 and Erk1/2; and proliferation and growth by Grb2 and PI3K (Boccaccio, et al. 
1998; Fan, et al. 2005; Maroun, et al. 1999; Maroun, et al. 2000; Trusolino, et al. 2010)  
In addition of these phosphorylations, there are other regulatory sites within the ǃ-subunit; 
in the juxtamembrane domain the phosphorylation of serine 956 and tyrosine 1093 have 
negative regulatory functions (Ma et al. 2003) which are involved in the receptor 
internalization after activation (Kermorgant and Parker 2005) and posterior degradation by 
ubiquitin-proteosome pathway (Jeffers, et al. 1997).  
Functions elicited by HGF are particularly important for liver repair and regeneration after 
liver injury by alcohol, drugs, viral infections or partial hepatectomy. In fact, HGF was 
originally discovered as a potent mitogen of adult rat hepatocytes (Nakamura, 1984). HGF is 
produced in the liver by non-parenchymal cells, such as HSC, sinusoidal endothelial, 
Kupffer cells and immune cells; but also it can be produced by other distant organs in the 
body, including lungs, and kidneys where it displays repair process as well. (Grenier, et al. 
2002; Nakamura and Mizuno 2010; Taieb, et al. 2002b).  
In healthy humans circulating levels of HGF are always present, and can be affected by age, 
gender and pregnancy. It can be established a normal range from 0.26 to 0.39 ng/ml, 
however it is well known the increase in serum HGF after both, acute and chronic liver 
damage (Funakoshi and Nakamura 2003), and this increment depends on the kind of 
damage or disease. For example, in alcoholic liver cirrhosis the HGF levels reported is 0.78 
ng/ml (Antoljak, et al. 2001), in patients with hepatocarcinoma the average level is 1.06 ± 
1.45 ng/ml and in patients with fulminant hepatitis it could reach values of 16.40 ± 14.67 
ng/ml (Funakoshi and Nakamura 2003). The increment shows a positive correlation with 
markers of liver failure such as serum bilirubin or gamma-glutamyl transpeptidase, and  
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Fig. 1. Signaling pathways and effects elicited by HGF/c-Met. HGF, hepatocyte growth 
factor; Grb2, growth factor receptor-bound protein 2; Grb1 binding-associated binder1; 
PI3K, phosphoinositide-3-kinase; STAT3, signal transducer and activator of transcription 3; 
PLCǄ, Phospholipase C gamma; SOS, son of sevenless, guanine nucleotide exchange factor; 
RAS, rat sarcoma, GTPase; Akt, Protein Kinase B; NF-κB, nuclear factor kappa B. 
negative correlation with albumin content, suggesting that HGF levels can reflect the grade 
of illness and can be considered as a prognosis indicator.  
The main evidence of the relevance of HGF on liver regeneration and repair came with the 
creation of the hepatocyte-specific c-Met signaling deletion mouse (MetKO) (Huh, et al. 
2004). Loss of c-Met signaling appeared not to be detrimental to hepatocyte function under 
physiological conditions, but sublethal doses of Fas agonist (Jo2 antibody) induced a 
hypersensitization to damage generating massive liver apoptosis and necrosis, with no 
important effects in wild type mouse. Hepatocytes derived from MetKO mice exhibited 
sensitization to Jo2-induced apoptosis and impairment in motility and phagocytosis, 
activities which are required for a proper repair process (Gomez-Quiroz et al. 2008; Huh et 
al. 2004) 
3. HGF and c-Met in alcoholic liver disease 
Functions of HGF in ALD remains partially characterized. However it is clear that HGF and 
c-Met are involved in every stage of ALD, from inflammatory response to alcoholic 
steatohepatitis, fibrosis, cirrhosis and hepatocarcinoma (Cornella, et al. 2011; Tahara, et al. 
1999; Taieb et al. 2002b). 
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3.1 Ethanol impairs HGF release from neutrophils 
Ethanol-initiated damage lead to an inflammatory response characterized by neutrophilia 
and hepatic polymorphonuclear neutrophil (PMN) infiltration (Taieb et al. 2002b). We 
reported previously that acetaldehyde, the main metabolite of ethanol biotransformation, 
induces the production of IL-8, chemotactic factor for PMN, in HepG2 cells (Gomez-Quiroz, 
et al. 2003) and Taieb and coworkers (Taieb et al. 2002b) have shown that PMN are an 
important source of HGF specifically in patients with severe alcoholic hepatitis, finding that 
these patients presented higher levels of HGF (6.07 ± 0.738 ng/ml) in comparison with 
alcoholic hepatitis-free patients with cirrhosis (3.24 ± 0.438 ng/ml) and healthy controls 
(0.407 ± 0.027 ng/ml). Hepatic HGF levels correlated with the degree of hepatic PMN 
infiltration (P=0.0015, ρ=0.76). This study provides evidences that PMN cells are an 
important source of HGF, particularly in patients with large PMN infiltration, pointing out 
the PMN cells as coadjutants in liver repair, at least in acute processes.  
Although PMN cells provide HGF to the injured liver, ethanol inhibits this effect. PMN cells 
treated with degranulation promoter agents (cytochalasin B and N-formyl-methionyl-leucyl-
phenylalanine) induced the release of HGF, however the presence of different 
concentrations of ethanol significantly inhibited HGF degranulation in a concentration-
dependent manner (Taieb, et al. 2002a), indicating that ethanol impairs HGF release from 
PMN cells obstructing liver repair process. 
3.2 Free radicals, oxidative stress and ethanol metabolism  
In terms of ethanol metabolism-induced oxidative stress, we can define two main levels of 
HGF-mediated protection. The first level is generating system regulation, particularly the 
microsomal ethanol oxidizing system (MEOS), and the second one is the control or 
neutralization of the free radicals formed as a consequence of ethanol metabolism. 
A free radical is a molecule or atom that contains one or more unpaired electron, this 
characteristic makes them highly instable and reactive. In the cellular context, oxygen and 
nitrogen free radicals have a wide variety of actions ranging from modulation of gene 
expression to the induction of cell death.  
Physiologically 1-2% of molecular oxygen is converted, by enzymatic and non-enzymatic 
mechanisms, to reactive oxygen species (ROS) which include hydrogen peroxide (H2O2), 
superoxide anion (O2), singlet molecular oxygen (1O2), hydroxyl (HO), alkoxyl (RO), and 
Peroxyl (ROO) radicals (Cadenas 1989). In order to avoid the harmful effects of these 
molecules, cells enclose a battery of antioxidant defenses which include enzymatic and non-
enzymatic components. Among the antioxidant enzymes superoxide dismutase (SOD), 
catalase,  glutathione (GSH) peroxidase (GSHPx) and GSH reductase (GSHRd) sustain the 
major detoxifying activities. SOD1, 2 and 3 which are located in cytosol, mitochondria and 
plasma membrane respectively drive the transformation of O2 in H2O2, although hydrogen 
peroxide is not a free radical, it is the precursor of the highest reactive and toxic specie 
among the ROS, the hydroxyl radical via either, Fenton reaction, which requires the 
presence of Fe3+ or Cu2+ for the process, or Haber-Weiss reaction. (Valko, et al. 2007)  
To counteract this phenomenon H2O2 is transformed to H2O by the action of catalase or 
GSHPx. GSHPx uses two molecules of GSH to reduce H2O2, generating the oxidized form of 
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glutathione (GSSG) which can be regenerated to GSH by the action of GSHRd using 
NADPH as electron donor.  
GSH is the naturally occurring major thiol. It is produced in the cytosol by the action of two 
enzymes, the Ǆ-glutamyl cysteine ligase (also known as Ǆ-glutamyl cysteine synthetase, Ǆ-
GCS) that catalyses the formation of the dipetide L-Ǆ-glutamyl-L-cysteine, and by glutathione 
synthase which converts this dipeptide in GSH (L-Ǆ-glutamyl-L-cysteinyl-Glycine). 
The ability of GSH to deal with ROS is not restricted as a cofactor of GSHPx, because GSH 
has, by itself, the capacity to scavenge free radicals, as it happens with others non-enzymatic 
antioxidants such as vitamin C and E, and ǃ-carotene . 
Ethanol metabolism  is mainly driven by both, alcohol dehydrogenase and MEOS which 
main member is cytochrome P450 (Cyp) 2E1, both enzymes generate acetaldehyde as 
primary metabolite, but only MEOS produces, in addition, ROS such as O2, H2O2, and the 
highly toxic HO, responsible of DNA, protein and lipid oxidation (Cadenas 1989). It has 
been reported that Cyp2E1 is induced by ethanol consumption principally in zone 3 
hepatocytes. Biopsies from recently drinking subjects revealed an increment from 4- to 10-
fold over normal values (Tsutsumi, et al. 1989). 
 
Fig. 2. Major alcohol metabolism processes. EtOH, ethanol; ADH, alcohol dehydrogenase; 
AldDH, aldeyde dehydrogenase; ROS, reactive oxygen species; MEOS, microsomal ethanol 
oxidizing system; NADH, reduced nicotine adenine dinucleotide.  
Other Cyp isoforms have been implicated in ethanol metabolism, such as Cyp1A2 and 
Cyp3A4, thus the term MEOS characterizes the total microsomal ethanol oxidation, not only 
Cyp2E1 (Salmela, et al. 1998). 
3.3 HGF regulates the ROS generating systems 
Donato and coworkers reported in 1998 that HGF regulates the expression and activities of 
Cyp1A1/2, Cyp2A6, Cyp2E1 and, Cyp2B6 in human hepatocytes in primary culture 
(Donato, et al. 1998). Activities of Cyp1A2, Cyp3A4 and Cyp1A1/2 were significantly 
diminished at 72 h of HGF treatment (10 ng/ml). Particularly in five hepatocytes cultures 
from five different healthy donors, HGF treatment resulted in the reduction of Cyp2E1 
activity ranging from 55 to 69% regarding not treated cultures. These effects were correlated 
with the decrease in the corresponding mRNA, suggesting that HGF transcriptionally and 
post-translationally downregulates some of the MEOS components. This regulation 
represents the first frontline of HGF-induced defense against the toxicity of ethanol.  
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In addition to the abrogation of MEOS components by HGF, it is reported that it can also 
downregulate another ROS generating systems such as NADPH oxidase (Gomez-Quiroz et 
al. 2008), which is involved  in many liver diseases such as fibrosis(De Minicis, et al. 2010), 
hepatitis C virus infection (de Mochel, et al. 2010) and alcoholic liver disease where it is 
mainly activated in Kupffer cells  leading to TNF- production (Kono, et al. 2000). 
3.4 HGF regulates the ROS produced by ethanol metabolism 
The second HGF frontline against the oxidative effect of ethanol metabolism is leaded by the 
generation of antioxidants. It is well known that HGF/c-Met can regulate the activation of 
survival transcription factors such as NF-κB or Nrf2 (Gomez-Quiroz et al. 2008; Kaposi-
Novak, et al. 2006; Valdes-Arzate, et al. 2009) which are responsible of the expression of a 
wide range of antioxidant, detoxifying and antiapoptotic proteins and it has been well 
documented elsewhere (Fan et al. 2005; Klaassen and Reisman 2010).  
In vitro studies have revealed the prominent role of HGF in cellular survival against ethanol 
toxicity. One of the main problems to address the molecular mechanism of alcohol induced 
damage, at the cellular level, is that hepatocytes in primary culture loss the capacity to 
metabolize ethanol due to a downregulation in the MEOS and alcohol dehydrogenase. Cell 
lines expressing stable and constitutively Cyp2E1 and/or alcohol dehydrogenase have been 
established to sort the inconvenience in the absent of alcohol metabolism in normal 
hepatocytes in culture (Chen and Cederbaum 1998; Donohue, et al. 2006), particularly 
relevant is the cell line VL17A, which is a suitable in vitro model of ALD due to the 
expression of both Cyp2E1 and alcohol dehydrogenase (Donohue et al. 2006), which mimics 
much better conditions in normal hepatocytes than single gene transfected cells (Chen and 
Cederbaum 1998).  
VL17A have been used to address the mechanism of HGF-induced protection in ALD 
(Valdez-Arzate 2009). HGF was capable to decrease ROS production, protein oxidation and 
lipid peroxidation damage due to ethanol metabolism, correlating with an increase in cell 
viability. Analysis of the mechanism involved in the HGF-induced protection against 
ethanol metabolism toxicity revealed that HGF induces the activation of NF-κB, with a 
concomitant expression of antioxidant enzymes such as catalase, SOD1, and Ǆ-GCS, as well 
as an elevation in GSH synthesis as a consequence of the expression of Ǆ-GCS. Inhibition of 
NF-κB, or the main upstream activators of this transcription factor (PI3K and Akt), 
significantly abrogated the protective role of HGF (Gomez-Quiroz et al. 2008; Valdes-Arzate 
et al. 2009) 
HGF has demonstrated to increase the expression of catalse and GSHRd (Arends, et al. 
2008). Catalase transforms H2O2 in H2O, and GSHRd restores GSH from GSSG (Figure 2). 
It has been widely characterized the relevance of GSH in ALD by Fernandez-Checa and 
coworkers (Fernandez-Checa, et al. 2002; Fernandez-Checa, et al. 1993; Fernandez-Checa, et 
al. 1996; Hirano, et al. 1992), and it is proposed as one of the key mechanism in the alcohol-
induced hepatocellular damage, mainly by GSH depletion in mitochondria.  
HGF has shown regulate strongly GSH homeostasis by inducing the expression of Ǆ-GCS 
(Tsuboi 1999; Valdes-Arzate et al. 2009), and we are claiming that this is the main 
mechanism of protection against oxidative stress. In fact, c-Met KO mice are under oxidative 
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stress due to the increment in the NADPH oxidase activity, and depletion in GSH. MetKO 
mice subjected to the carcinogenic agent N-nitrosodiethylamine were more susceptible to 
the development of tumors in the liver, presenting an increment in multiplicity, size and 
incidence. This effect was abrogated by the oral administration of N-acetyl cysteine (NAC) 
which is precursor of GSH synthesis (Takami, et al. 2007). These findings were correlated in 
in vitro studies, MetKO hepatocytes are more susceptible to Jo2-induced damage, effect that 
was abrogated by NAC treatment, which induced GSH reservoirs restoration (Gomez-
Quiroz et al. 2008).  
The main consequence in ROS generation is the induction of hepatocytes apoptosis. ROS can 
induce the activation of jun kinease signaling pathway leading to the activation of AP-1 
transcription factor that promotes the expression of proapoptotic proteins such as FasL, 
TNF- and Bak. ROS also targets mitochondria inducing membrane permeabilization and 
the release of proapoptotic proteins (cytochorme c, Smac/diablo, EndoG, among 
others(Serviddio, et al. 2010), which participate in the cell death process.  
 
Fig. 3. Alcohol-mediated reactive oxygen species production and antioxidant response 
driven by HGF. Molecules downregulated (red) and upregulated (green) by HGF. EtOH, 
ethanol; MEOS, microsomal ethanol oxidizing system, Ald, Acetaldehyde; H2O2, hydrogen 
peroxide; O2,  superoxide anion; HO,hydroxyl; SOD, Superoxide Dismutase; Cat, catalase; 
GSH Glutathione; GSHPX, Glutathione peroxidasa; Gluatathione –reductase; GSSG, 
Oxidized glutathione; Ǆ-GCS, Ǆ-glutamyl cysteine synthetase; GS, Glutathione Synthase.  
It is well known the antiapoptotic effect of HGF, not only in hepatocytes, but in many cell 
types (Arends et al. 2008; Fan et al. 2005; Kitta, et al. 2001; Santangelo, et al. 2007). In 
addition to the control of ROS, HGF can induce the expression of antiapoptotic proteins by 
the activation of survival canonical pathways for example, Akt/NF-κB, Erk1/2 or Stat3, 
which induce Bcl2, Bcl-XL, and Mcl-1 expression (Gomez-Quiroz et al. 2008; Valdes-Arzate 
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et al. 2009), but also HGF-induction of GSH supports its antiapoptotic function, based in the 
fact that NAC treatment significantly reduced the Jo2-induced apoptosis in hepatocytes, and 
pretreatment with BSO, an inhibitor of Ǆ-GCS, abrogated the protective effect of both NAC 
and HGF(Gomez-Quiroz et al. 2008). 
The evidence gathered here clearly shows the central role of HGF in the control of ethanol-
induced oxidative stress and GSH homeostasis as key issues in the hepatoprotective 
mechanism in ALD (Figure 2). 
3.5 Regulation of lipid homeostasis and recovery from alcohol-induced fatty liver 
The mechanism of alcohol-induced fatty liver disease is complex and remains not fully 
characterized. The main mechanism proposed is that alcohol impacts at three levels.  
The first level is the induction of oxidative stress, starting by MEOS, and continuing with 
mitochondria dysfunction due to a decrease in mitochondrial GSH reservoirs. The second 
level is the increase in TNF-, which augments mitochondria failure, and ROS production 
and deregulates adiponectin, which promotes fatty acids oxidation. The third level is the 
activation of transcription factors involved in lipid biosynthesis and export.  
Liver packages triglycerides into a very low density lipoproteins (VLDL), forming a 
complex with the apolipoprotein B 100 in a process facilitated by the microsomal 
triglyceride transfer protein (MTTP), which is downregulated in rats fed with an ethanol-
containing liquid diet (Sugimoto, et al. 2002). The first and second levels converge in the 
generation of endoplasmic reticulum (ER) stress and in the increment in the activation of 
sterol regulatory element binding protein 1c (SREBP1c), which is in the third level. 
SREBP1c is a transcription factor that remains inactivated in ER, and after stimulus, 
migrates to the Golgi for further process and finally arrives to the nucleus where it 
promotes the expression of genes involved in fatty acids synthesis (Ferre and Foufelle 
2010). Furthermore, the AMP-activated protein kinase (AMPK), a serine-threonine kinase, 
which stimulates both, fatty acid oxidation by the activation of the peroxisome 
proliferator-activated receptors alpha (PPARǂ) and glycolisis, and inhibits fatty acid 
synthesis due to the inactivation of acetyl-CoA carboxylase (ACC), leads to the decrease 
of malonyl-CoA, a precursor in fatty acid synthesis and inhibitor of the carnitine 
palmitoyl transferase 1, the rate-limiting enzyme in fatty acid oxidation (Dobrzyn, et al. 
2004; Hardie and Pan 2002). AMPK also inhibits the activation of SREBP1c, presenting 
AMPK as a multimodal regulator of lipid metabolism in the liver. Animals fed with an 
alcohol-containing diet exhibit a decrease in the activity of AMPK resulting in the 
development of hepatic steatosis (Garcia-Villafranca, et al. 2008). 
In addition, it has been proposed that the increase in NADH/NAD+ ratio due to alcohol 
metabolism drives the inhibition of the tricarboxylic acids cycle and fatty acid oxidation, but 
also it can induce ER stress (figure 3) (Lieber 2004) 
HGF involvement in lipid homeostasis has been experimentally demonstrated, Kaibori and 
collaborators reported that HGF is capable to induce lipid synthesis under liver regeneration 
(Kaibori, et al. 1998), and the genetic elimination of c-Met signaling in hepatocytes induced 
changes in the expression of many proteins related to lipid metabolism such as Acox1, ASS1, 
Crot, Cyp4a10, Cyp 4a14, Fasn, Lipc, among others (Kaposi-Novak et al. 2006). 
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One of the firsts studies focused to address  the regulation of alcohol-induced fatty liver by 
HGF was reported in 1999 by Tahara and collaborators (Tahara et al. 1999), they observed 
that rats fed with an ethanol containing diet for 30 days developed hepatic steatosis. The 
administration of HGF for 7 days (37 days on the diet) reduced lipid deposition in liver 
tissue. The major mechanism observed was the increment on lipid secretion via VLDL by 
the induction of ApoB100 expression. 
The second HGF effect related to steatosis control is the restoration of the mRNA levels and 
activity of MTTP. Injection of HGF on animals subjected to an alcoholic diet restored MTTP 
levels,  this observation was corroborated in HepG2 cells which were exposed to HGF 
resulting an enhanced expression of both MTTP and ApoB100 (Sugimoto et al. 2002).   
The induction of VLDL and MTTP by HGF seems not to be exclusive for alcohol-induced 
steatosis, due to Kosone and collaborators (Kosone, et al. 2007) found the same results in a 
model of fatty liver generated by a high-fat diet and confirmed in HepG2 cells the decrease 
in lipid content. 
Another evidence of HGF-induced alcoholic steatosis protection comes from the effect of 
pioglitazone, this drug is used in the treatment of diabetes and non-alcoholic 
steatoshepatitis, but it has been postulated that it can be also used in the treatment of 
alcoholic steatohepatitis (Tomita, et al. 2004). Ethanol reduced the mRNA and protein levels 
of c-Met, and pioglitazone restored the c-Met expression decreasing the lipid content in liver 
tissue. Both HGF and pioglitazone showed downregulate the expression of key genes 
involved in lipid homeostasis such as SREBP 1c and stearoyl-CoA desaturase, improving the 
deleterious effects in the alcoholic fatty liver. 
Finally, recently has been published that HGF can promote the activation of AMPK 
signaling pathway (Chanda, et al. 2009) inducing the suppression on lipid synthesis and 
gluconeogenesis. 
3.6 Fibrosis 
The main consequence in the chronic alcohol ingestion is liver fibrosis/cirrhosis which is 
characterized by the hyper-accumulation of connective tissue components, mainly collagen, 
and a disorganization of the normal hepatic structure of regenerative nodules. Many reports 
have clarified the preventive and therapeutic effects of HGF on liver fibrosis or cirrhosis 
(Inagaki, et al. 2008; Jones, et al. 2010; Matsuda, et al. 1995; Matsuda, et al. 1997; Ueki, et al. 
1999; Xia, et al. 2006). 
HGF treatment in animals challenged with different inducers of liver fibrosis suppressed the 
connective tissue components expression and hydroxyproline levels, preventing the onset of 
scar formation (Matsuda et al. 1997). The mechanism of HGF-induced anti-fibrotic 
protection is focused to antagonize the transforming growth factor beta (TGF-ǃ) signaling 
pathway. TGF-ǃ is the main profibrogenic factor, inducing the expression of collagen, 
fibronectin and hepatocytes apoptosis. The effect of HGF on TGF-ǃ has been observed at 
different levels. In the model of fibrosis induced by the bile duct ligation, HGF showed 
suppress the expression of TGF-ǃ and the conversion bile duct epithelial to mesenchymal 
transition (Xia et al. 2006). TGF-ǃ suppression by HGF was also observed in the model of 
DEN-induced fibrosis (Ueki et al. 1999).  
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Fig. 4. Molecular mechanism of ethanol-mediated lipid deposition in the liver. Molecules or 
processes downregulated (red) and upregulated (green) by HGF. EtOH, ethanol; TNF-α, 
Tumor necrosis factor-alpha; ROS, reactive oxygen species; ER, Endoplasmic reticulum; 
NADH, Nicotine Adenine dinucleotide reduced; SREBP1c,  sterol regulatory element 
binding protein 1c; AMPK, AMP-activated protein kinase; MTTP, microsomal triglyceride 
transfer protein; VLDL, very low density lipoproteins; PPAR-ǂ; peroxisome proliferator-
activated receptors alpha; FA, Fatty acid. 
Another study showed that HGF decreased the expression of collagen 1A2 gene in a model 
of fibrosis induced by carbon tetrachloride by a mechanism dependent of the nuclear export 
of smad3 mediated by galectin-7 (Inagaki et al. 2008). 
Recently an innovator system to study the anti-fibrotic and protective effect of HGF was 
developed (Jones et al. 2010). HGF was mixed with collagen and robotically printed onto 
standard glass slides to create arrays of 500 µm diameter spots, and then rat hepatocytes 
were seeded and challenged with 100 mM ethanol. Results showed that hepatocytes in the 
HGF-containing collagen spots presented less apoptosis comparing with those seeded in 
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HGF-free spots. To investigate impact on the fibrosis, a mix of hepatocytes and HSC were 
seeded and again challenged with alcohol. HSC were less activated (less fibrotic) in spots 
containing HGF compared to control. This in vitro study confirms the anti-fibrotic response 
of HGF 
3.7 HGF, alcohol and cancer 
Heavy long-term alcohol drinking ( ≥69.0 g alcohol/day in men, and ≥ 23.0 g alcohol/day in 
women) is a significant risk factor for the development of hepatocellular carcinoma (HCC) 
(Shimazu et al. 2011) . There is no efficient animal model to study the direct mechanism of 
alcohol-induced HCC, recently it has been reported that rats selectively bred for high 
alcohol preference with free access to water supplemented with 10% ethanol for 18 months 
developed hepatic neoplasia, ERK pathway activation, increased Cyp2E1 activity and 
oxidative stress (Yip-Schneider et al. 2011). As mentioned here, ethanol metabolism is the 
main harmful mechanism, due to ROS production; in addition ethanol increases the 
infiltration of inflammatory cells enhancing the oxidative damage, accelerating telomere 
shortening and favoring oncogenic mutation (Cornellá et al. 2011) in the carcinogenesis 
process.  
The HGF functions, previously described inhere; strongly suggest the prominent role of this 
growth factor in the prevention of HCC. In fact, MetKO mice exhibited an accelerated DEN-
induced hepatocarcinogenesis, demonstrating the protective and preventive roles of HGF in 
liver carcinogenesis (Takami et al. 2007), in this study, the accelerated tumor development 
was associated with increased rate of cell proliferation and prolonged activation of 
epidermal growth factor receptor (EGFR) signaling, MetKO mice also exhibited an elevated 
lipid peroxidation, decreased levels of GSH, and SOD expression increment, suggesting that 
oxidative stress could be a determinant factor for the acceleration of hepatocarcinogenesis. 
MetKO mice were more susceptible than WT mice to DEN-induced liver cancer increasing 
multiplicity, incidence and size of tumors. The negative effects of c-Met deletion were 
reversed by the chronic administration of NAC, blocking EGFR activation and reducing 
initiated hepatocarcinogenesis, confirming that c-Met deletion-induced oxidative stress is 
the main hallmark in the accelerated carcinogenesis and that c-Met integrity is required as a 
protective mechanism against chemical-induced carcinogenesis by the induction of 
cytoprotective enzymes such as antioxidant enzymes. 
In contrast, a wide variety of human tumors exhibit sustained activation, overexpression or 
mutation of c-Met, including liver tumors. It is not hard to imagine that beneficial and 
protective roles of HGF in all stages of alcoholic liver disease are not longing in liver cancer. 
HGF-induced protection ends in the early stages of hepatocarcinogenesis. Once initiated the 
carcinogenic process, HGF and c-Met trigger signaling cascades resulting in proliferation, 
growth, survival, motogenesis and angiogenesis (Eder et al. 2009). Mouse and human cell 
lines that overexpress c-Met or/and HGF become tumorigenic and metastatic in athymic 
mice (Rong et al. 1994) and, in contrast, downregulation of c-Met or HGF expression 
decreases tumorigenic potential (Abounader et al., 2002), in fact, overexpression of c-Met or 
HFG are associated with poor prognosis and aggressive phenotype (Kaposi-Novak et al. 
2006). In summary HGF/c-Met protects from carcinogenesis, but in established tumors 
induces the aggravation of the disease. Mutations in c-Met and HGF predispose to human 
cancer.   
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4. Conclusion 
In conclusion HGF and c-Met are introduced as promissory therapeutic targets for the 
treatment of ALD, they can reverse or abrogate almost every stage of the disease, controlling 
the metabolism, the harmful molecules, the lipid homeostasis disturbing and the chronic 
effects of alcohol consumption. Although more research is needed to figure out the proper 
point of intervention in the signaling activated by HGF and c-Met, the experimental 
evidences gathered here support the promising success of HGF/c-Met.  
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